Addressing Tumor Board Bad Habits and Risks: A Call for Rational Resource Management Fig 1. Summary of germline and somatic genomic testing for metastatic prostate cancer recommendations. ARPI, ...

From 7% to nearly 9% of patients with advanced cancer were found to harbor a germline variant with targeted therapeutic actionability in the first study of its kind. The study involved 11,974 patients ...

What is the importance of family history collection in the setting of germline multigene panel testing, and what elements of family history are most important? When and how should multigene panel ...

More evidence points to the benefits of germline genetic testing for patients with various cancers. Such testing can identify mutations that may warrant a change of treatment and allow trying a ...

NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, announced today the launch of a new line of germline cancer predisposition testing services. The new ...

Credit: Getty Images Determining the presence or absence of gene mutations associated with aggressive prostate cancer can have implications for risk stratification, monitoring, and therapy. Genetic ...

Please provide your email address to receive an email when new articles are posted on . Nearly all individuals who self-navigated the entire online platform completed germline testing. The platform ...

Multigene NGS on tumor tissue accurately identifies pathogenic variants in EOC, supporting a tumor-first genetic testing model. The study found 94.3% of tumors had detectable variants, with 99.1% ...

Personalized treatment strategies are increasingly important in managing lung cancer brain metastases, incorporating targeted therapies and immunotherapies. Stereotactic radiosurgery and whole-brain ...

BOSTON & EL MONTE, Calif.--(BUSINESS WIRE)--Foundation Medicine, Inc., a genomics company committed to transforming cancer care, today announced plans to launch two new germline tests, ...